Researcher.Life Logo

Rational Pharmacotherapy in Cardiology : Impact Factor & More

eISSN: 2225-3653pISSN: 1819-6446
JournalOpen Access

Key Metrics

CiteScore
0.9
H-Index
11
SJR
Q4Pharmacology (medical)
SNIP
0.32
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Rational Pharmacotherapy in Cardiology

Rational Pharmacotherapy in Cardiology Journal Specifications

Overview
Publisher SOC CARDIOLOGY RUSSIAN FEDERAT
Language Russian,English
Frequency Bi-monthly
Publication Time6
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian,English
Society/Institute/SponsorRussian Society of Cardiology
FrequencyBi-monthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in Rational Pharmacotherapy in Cardiology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Rational Pharmacotherapy in Cardiology

The role of left atrial strain in predicting cardiovascular outcomes in patients with type 2 diabetes and intermediate probability of heart failure with preserved ejection fraction
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Assessment of the need pacemaker implantation following aortic valve replacement with combined cardiac surgery
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Impact of early administration of empagliflozin in patients with acute decompensated heart failure on medium-term prognosis (3 and 6 months)
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Cytokine hemoadsorption in myocardial infarction-associated cardiogenic shock: protocol for a randomized clinical trial
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Pleiotropic properties of direct oral anticoagulants — new therapeutic horizons
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Functional state of terminal muscular arteries and distributing arterioles in men with different levels of psychosocial stress
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
The role of left atrial strain in predicting cardiovascular outcomes in patients with type 2 diabetes and intermediate probability of heart failure with preserved ejection fraction
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Assessment of the need pacemaker implantation following aortic valve replacement with combined cardiac surgery
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Impact of early administration of empagliflozin in patients with acute decompensated heart failure on medium-term prognosis (3 and 6 months)
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Cytokine hemoadsorption in myocardial infarction-associated cardiogenic shock: protocol for a randomized clinical trial
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Pleiotropic properties of direct oral anticoagulants — new therapeutic horizons
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology
Functional state of terminal muscular arteries and distributing arterioles in men with different levels of psychosocial stress
  • 25 Oct 2025
  • Rational Pharmacotherapy in Cardiology

FAQs on Rational Pharmacotherapy in Cardiology